Cingulate Inc. Company Profile
NASDAQ: CINGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.87-0.02 (-0.41%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cingulate at a glance
Cingulate Inc. (NASDAQ: CING) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $71.1 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001862150, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Cingulate Inc.
- Ticker
- NASDAQ: CING
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2021
- Market cap
- $71.11M
- SEC CIK
- 0001862150
Companies similar to Cingulate
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VRCAVerrica Pharmaceuticals Inc. | 4.14 | -1.66% | $71.12M | vs CING |
| TENXTenax Therapeutics Inc. | 1.91 | -1.04% | $71.48M | vs CING |
| HYFTMindWalk Holdings Corp. | 1.50 | -3.23% | $70.67M | vs CING |
| OSTXOS Therapies Incorporated | 1.55 | +4.03% | $72.55M | vs CING |
| MAIAMAIA Biotechnology Inc. | 1.18 | -0.84% | $72.86M | vs CING |
| GANXGain Therapeutics Inc. | 1.67 | 0.00% | $72.88M | vs CING |
| HRTXHeron Therapeutics Inc. | 0.3843 | +15.86% | $72.96M | vs CING |
| NMADNomad Power Solutions Inc. | 4.25 | -2.19% | $68.43M | vs CING |